Influence of intravenous drug abuse on vascular access placement and survival in HIV-seropositive patients

Nephron - Clinical Practice

Volumn 100, Issue 2, 2005, Pages

  Eustace, Joseph A ^a,b   Gregory, Peter C ^a   Krishnan, Mahesh ^a   Ni, Wen ^a   Kuhn, Doreen M ^a   Astor, Brad C ^a   Scheel Jr , Paul J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous fistula; Arteriovenous graft; Catheters; Human immunovirus; Intravenous drug abuse

Indexed keywords

SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS FISTULA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT INFECTION; HAZARD ASSESSMENT; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INTRAVASCULAR CATHETER; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL RATE; VASCULAR ACCESS; VEIN GRAFT;

ADULT; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 20944447067     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085031     Document Type: Article

References (32)

1. National Kidney Foundation DOQI (Kidney Disease Outcomes Quality Initiative 2000 UPDATE), Clinical Practice Guidelines. American Journal of Kidney Diseases 2001;37(suppl 1):S1-238.
2. Churchill DN, Taylor DW, Cook RJ, et al: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992;19:214-234.
3. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al: Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986;152:238-243.
4. Mehta S: Statistical summary of clinical results of vascular access procedures for haemodialysis; in Sommer BG, Henry ML (eds): Vascular Access for Hemodialysis-II. New York, Gore & Associates, 1991, pp 145-157.
5. Astor BC, Coresh J, Powe NR, et al: Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis 2000;36:1126-1134.
6. Woods JD, Turenne MN, Strawderman RL, et al: Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 1997;30:50-57.
7. Brock JS, Sussman M, Wamsley M, et al: The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 1992;16:904-910: discussion 911-912.
8. Curi MA, Pappas PJ, Silva MB, et al: Hemodialysis access: Influence of the human immunodeficiency virus on patency and infection rates. J Vasc Surg 1999;29:608-616.
9. Whigham CJ, Goodman CJ, Fisher RG, et al: Infectious complications of 393 peripherally implantable venous access devices in HIV-positive and HIV-negative patients. J Vasc Interv Radiol 1999;10:71-77.
10. Klotman PE: HIV-associated nephropathy. Kidney Int 1999;56:1161-1176.
11. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535.
12. Cheng BC, Cheng KK, Lai ST, et al: Long term result of PTFE graft for hemodialytic vascular access. J Surg Assoc 1992;25:1070-1076.
13. Kimmel PL, Bosch JP, Vassalotti JA: Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 1998;18:446-458.
14. Trerotola SO, Scheel PJ, Powe NR, et al: Screening for dialysis access graft malfunction: Comparison of physical examination with US. J Vasc Interv Radiol 1996;7:15-20.
15. Windus DW, Audrain J, Vanderson R, et al: Optimization of high-efficiency dialysis by detection and correction of vascular access dysfunction. Kidney Int 1990;38:337-341.
16. Schwab SJ, Raymond JR, Saeed M, et al: Prevention of hemodialysis fistula thrombosis: Early detection of venous stenoses. Kidney Int 1989;36:707-711.
17. Crain MR, Mewissen MW, Ostrowski GJ, et al: Fibrin sleeve stripping for salvage of failing hemodialysis catheters: Technique and initial results. Radiology 1996;198:41-44.
18. Suhocki PV, Conlon PJ, Knelson MH, et al: Silastic cuffed catheters for hemodialysis vascular access: Thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996;28:379-386.
19. Schwab SJ, Beathard G: The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int 1999;56:1-17.
20. Lin DY, Wei LJ: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-1078.
21. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
22. Jaar BG, Hermann JA, Furth SL, et al: Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis 2000;35:282-292.
23. Ortiz C, Meneses R, Jaffe D, et al: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988;34:248-253.
24. Dave MB, Shabih K, Blum S: Maintenance hemodialysis in patients with HIV-associated nephropathy. Clin Nephrol 1998;50:367-374.
25. Ifudu O, Mayers JD, Matthew JJ, et al: Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s? Am J Kidney Dis 1997;29:549-552.
26. Stonebridge PA, Edington D, Jenkins AM: 'Brachial/basilic vein' transposition for vascular access. J R Coll Surg Edinb 1995;40:219-220.
27. Gorski TF, Nguyen HQ, Gorski YC, et al: Lower-extremity saphenous vein transposition arteriovenous fistula: An alternative for hemodialysis access in AIDS patients. Am Surg 1998;64:338-340.
28. Nannery WM, Stoldt HS, Fares LG, 2nd: Hemodialysis access operations performed upon patients with human immunodeficiency virus. Surg Gynecol Obstet 1991;173:387-390.
29. Obialo CI, Robinson T, Brathwaite M: Hemodialysis vascular access: Variable thrombus-free survival in three subpopulations of black patients. Am J Kidney Dis 1998;31:250-256.
30. Kelsey JL, Thompson WL, Evans AS: Measurement Error. Methods In Observational Epidemiology. New York, Oxford University Press, 1986, chap 11, pp 285-308.
31. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH: Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-495.
32. Kaplowitz LG, Comstock JA, Landwehr DM, et al: A prospective study of infections in hemodialysis patients: Patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 1988;9:534-541.